Authors: Malonne, H Farinelle, S Decaestecker, C Gordower, L Fontaine, J Chaminade, F Saucier, JM Atassi, G Kiss, R

Citation: H. Malonne et al., In vitro and in vivo pharmacological characterizations of the antitumor properties of two new olivacine derivatives, S16020-2 and S30972-1, CLIN CANC R, 6(9), 2000, pp. 3774-3782

Authors: Mee, SL Chaminade, C Delaporte, C Markovits, J Saucier, JM Jacquemin-Sablon, A

Citation: Sl. Mee et al., Cellular resistance to the antitumor DNA topoisomerase II inhibitor S16020-2: Importance of the N-[2(dimethylamino)ethyl] carbamoyl side chain, MOLEC PHARM, 58(4), 2000, pp. 709-718

Authors: Khelifa, T Rene, B Le Mee, S Lambert, B Saucier, JM Markovits, J Jacquemin-Sablon, H Jacquemin-Sablon, A

Citation: T. Khelifa et al., Transfection of 9-hydroxyellipticine-resistant Chinese hamster fibroblastswith human topoisomerase II alpha cDNA: Selective restoration of the sensitivity to DNA religation inhibitors, CANCER RES, 59(19), 1999, pp. 4927-4936